［1］ Vespro V，Bonanno MC，Andrisani MC，et al. CT after lung microwave ablation：normal findings and evolution patterns of treated lesions［J］. Tomography， 2022， 8： 617- 626.
［2］ 中华人民共和国国家卫生健康委员会医政医管局． 原发性肝癌诊疗指南（2022年版）［J］． 中国实用外科杂志， 2022， 42：241- 273．
［3］ 叶 欣，王 俊，危志刚，等． 热消融治疗肺部亚实性结节专家共识（2021年版）［J］． 中国肺癌杂志， 2021， 24：305- 322．
［4］ Zhang G，Yang H，Zhu X，et al. A CT- based radiomics nomogram to predict complete ablation of pulmonary malignancy： a multicenter study［J］. Front Oncol， 2022， 12： 841678.
［5］ 邱金霞，尹永波，鲁 北，等． 实时影像融合介入导航系统在小肝癌微波消融中应用评价［J］． 介入放射学杂志， 2023， 32：663- 667．
［6］ Rossi G，Petrone MC，Healey AJ，et al. Approaching small neuro-endocrine tumors with radiofrequency ablation［J］. Diagnostics（Basel）， 2023， 13： 1561.
［7］ Zhou W， Yu M， Mao X， et al. Landscape of the peripheral immune response induced by local microwave ablation in patients with breast cancer［J］. Adv Sci（Weinh）， 2022， 9： e2200033.
［8］ Faraoni EY， O’Brien BJ， Strickland LN， et al. Radiofrequency ablation remodels the tumor microenvironment and promotes neutrophil- mediated abscopal immunomodulation in pancreatic cancer［J］. Cancer Immunol Res， 2023， 11： 4- 12.
［9］ Xiao W，Huang H，Zheng P，et al. The CXCL10/CXCR3 pathway contributes to the synergy of thermal ablation and PD- 1 blockade therapy against tumors［J］. Cancers（Basel）， 2023， 15： 1427.
［10］ Chen S， Zeng X， Su T， et al. Combinatory local ablation and immunotherapies for hepatocellular carcinoma： rationale，efficacy，and perspective［J］. Front Immunol， 2022，13： 1033000.
［11］ Lambin P， Rios- Velazquez E， Leijenaar R， et al. Radiomics： extracting more information from medical images using advanced feature analysis［J］. Eur J Cancer， 2012， 48： 441- 446.
［12］ Morris LGT， Riaz N， Desrichard A， et al. Pan- cancer analysis of intratumor heterogeneity as a prognostic determinant of survival［J］. Oncotarget， 2016， 7： 10051- 10063.
［13］ Liu J， Dang H，Wang XW. The significance of intertumor and intratumor heterogeneity in liver cancer［J］. Exp Mol Med， 2018， 50： e416.
［14］ 王 申，李 红，王 曦，等．影像组学在肝细胞癌TACE中的应用进展［J］． 介入放射学杂志， 2022， 31：829- 832．
［15］ Gu J，Tong T，Xu D，et al. Deep learning radiomics of ultrasono-graphy for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients： a multicenter study［J］. Cancer， 2023， 129： 356- 366.
［16］ Ghosn M， Solomon SB. Current management of oligometastatic lung cancer and future perspectives： results of thermal ablation as a local ablative therapy［J］. Cancers（Basel）， 2021， 13： 5202.
［17］ Kobe A，Kindler Y，Klotz E，et al. Fusion of preinterventional MR imaging with liver perfusion CT after RFA of hepatocellular carcinoma： early quantitative prediction of local recurrence［J］. Invest Radiol， 2021， 56： 188- 196.
［18］ Horvat N，Araujo- Filho JAB，Assuncao- Jr AN，et al. Radiomic analysis of mri to predict sustained complete response after radiofrequency ablation in patients with hepatocellular carcinoma：a pilot study［J］. Clinics（Sao Paulo）， 2021， 76： e2888.
［19］ Gu Y，Huang H，Tong Q，et al. Multi- view radiomics feature fusion reveals distinct immuno- oncological characteristics and clinical prognoses in hepatocellular carcinoma［J］. Cancers（Basel）， 2023， 15： 2338.
［20］ Guo L， Du S， Gao S， et al. Delta- radiomics based on dynamic contrast- enhanced MRI predicts pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy［J］. Cancers（Basel）， 2022， 14： 3515.
［21］ Liu B，Li C，Sun X et al. Assessment and prognostic value of immediate changes in post- ablation intratumor density hetero-geneity of pulmonary tumors via radiomics- based computed tomography features ［J］. Front Oncol，2021，11：615174.
［22］ Peng Z，Wu X，Li J，et al. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion［J］. Int J Hyperthermia，2022，39：688- 696.
［23］ Lv K， Cao X， Du Peng et al. Radiomics for the detection of microvascular invasion in hepatocellular carcinoma［J］. World J Gastroenterol，2022，28：2176- 2183.
［24］ Wu J， Ding W， Wang Y， et al. Radiomics analysis of ultrasound to predict recurrence of hepatocellular carcinoma after microwave ablation［J］. Int J Hyperthermia， 2022， 39： 595- 604.
［25］ Shan QY，Hu HT，Feng ST，et al. CT- based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation［J］. Cancer Imaging， 2019， 19： 11.
［26］ Zhang L，Cai P，Hou J，et al. Radiomics model based on gadoxetic acid disodium- enhanced MR imaging to predict hepatocellular carcinoma recurrence after curative ablation［J］. Cancer Manag Res， 2021， 13： 2785- 2796.
［27］ Peng W， Jiang X， Zhang W， et al. A radiomics- based model can predict recurrence- free survival of hepatocellular carcinoma after curative ablation［J］. Asian J Surg， 2023， 46： 2689- 2696.
［28］ Rizzo S，Botta F，Raimondi S，et al. Radiomics： the facts and the challenges of image analysis［J］. Eur Radiol Exp， 2018， 2： 36.
［29］ Liu F， Liu D， Wang K， et al. Deep learning radiomics based on contrast- enhanced ultrasound might optimize curative treatments for very- early or early- stage hepatocellular carcinoma patients［J］. Liver Cancer， 2020， 9： 397- 413.
［30］ Taghavi M， Staal F， Gomez Munoz F， et al. CT- based radiomics analysis before thermal ablation to predict local tumor progression for colorectal liver metastases［J］. Cardiovasc Intervent Radiol， 2021， 44： 913- 920.
［31］ Fang S，Lai L，Zhu J，et al. A radiomics signature- based nomogram to predict the progression- free survival of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization plus radiofrequency ablation［J］. Front Mol Biosci， 2021， 8： 662366.
［32］ Yuan C， Wang Z， Gu D， et al. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a radiomics nomogram［J］. Cancer Imaging， 2019， 19： 21.
［33］ Huang Z， Shu Z， Zhu RH， et al. Deep learning- based radiomics based on contrast- enhanced ultrasound predicts early recurrence and survival outcome in hepatocellular carcinoma［J］. World J Gastrointest Oncol， 2022， 14： 2380- 2392.
［34］ An C， Jiang Y， Huang Z， et al. Assessment of ablative margin after microwave ablation for hepatocellular carcinoma using deep learning- based deformable image registration［J］. Front Oncol， 2020， 10： 573316.